Marshall Wace’s Gilead Sciences GILD Stock Holding History

Marshall Wace’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200	Closed	-$24.5K	–	3390
2025 Q4	$24.5K	Buy	+200	New	+$24.3K	﹤0.01%	2814
2023 Q3	–	Sell	-127,200	Closed	-$9.8M	–	2376
2023 Q2	$9.8M	Buy	+127,200	New	+$10.1M	0.02%	735
2023 Q1	–	Sell	-68,300	Closed	-$5.86M	–	2826
2022 Q4	$5.86M	Buy	68,300 +5,400	+9%	+$428K	0.01%	1099
2022 Q3	$3.88M	Buy	+62,900	New	+$3.97M	0.01%	1568
2022 Q1	–	Sell	-205,000	Closed	-$14.9M	–	3576
2021 Q4	$14.9M	Sell	205,000 -93,900	-31%	-$6.47M	0.03%	616
2021 Q3	$20.9M	Buy	298,900 +283,300	+1,816%	+$19.9M	0.09%	257
2021 Q2	$1.07M	Sell	15,600 -24,500	-61%	-$1.64M	﹤0.01%	1774
2021 Q1	$2.59M	Buy	+40,100	New	+$2.59M	0.01%	1186

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Marshall Wace's GILD Position: Q1 2026 in Review

Marshall Wace increased its Gilead Sciences (GILD) stake by 191% in Q1 2026, buying an estimated $212M and bringing the position to 2,310,515 shares worth $322M. The position accounts for 0.32% of the portfolio, ranked #37.

Marshall Wace first reported a position in GILD in Q1 2014 and has held it in 41 quarters since. The position peaked at $421M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Marshall Wace held 2,310,515 shares of Gilead Sciences worth $322M as of Q1 2026.
Marshall Wace bought 1,517,130 Gilead Sciences shares in Q1 2026, an estimated $212M.
Gilead Sciences made up 0.32% of Marshall Wace's portfolio in Q1 2026, its #37 holding.
Marshall Wace first reported a position in Gilead Sciences in Q1 2014 and has held it in 41 quarters since.
Marshall Wace's Gilead Sciences position peaked at $421M in Q1 2023.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.